|
S.S. Belous, B.A. Nanaeva
The place of various topical forms of mesalazine in the treatment of ulcerative colitis
|
№9/10 / 2023
|
|
A.V. Yakubovsky, E.V. Sokolovskiy
Pyoderma gangrenosum in inflammatory bowel disease
|
№8 / 2023
|
|
I.V. Kozlova, T.A. Tikhonova
Irritable bowel syndrome and ulcerative colitis: touch points. Analysis of a clinical case
|
№2 / 2022
|
|
Yu.P. Uspensky (1, 2), Yu.A. Fominykh (1, 2), O.A. Kizimova (1), N.Yu. Kolgina (3)
The state of the psychoemotional sphere in patients with inflammatory bowel diseases
|
№2 / 2022
|
|
D.G. Novikov, P.O. Pakhtusova, A.N. Zolotov, M.A. Livzan, G.R. Bikbavova
Neutrophil extracellular traps: a new perspective on the pathogenesis of inflammatory bowel disease
|
№2 / 2022
|
|
G.N. Tarasova, A.A. Yakovlev, N.V. Dobaeva
Pathogenetic role of soluble intercellular adhesion molecule in inflammatory bowel diseases
|
№2 / 2019
|
|
G.R. Bikbavova, M.A. Livzan, O.E. Lopatina
Effect of micronutrient deficiency and dietary habits on the immune response and intestinal microbiocenosis in patients with inflammatory bowel diseases: a review
|
№2 / 2019
|
|
A.A. Lishchinskaya, A.V. Kagramanova, M.Yu. Zvyaglova, O.V. Knyazev, N.A. Fadeeva, D.S. Kulakov, A.I. Parfenov
Thromboembolic complications in patients with inflammatory bowel diseases
|
№2 / 2019
|
|
M.I. Skalinskaya (1), I.G. Bakulin (1), E.V. Skazyvaeva (1), Т.N. Zhigalova (1), K.N. Ryndin (1), M.V. Solovyev (2)
BIOLOGICAL PREPARATIONS IN THERAPY OF INFLAMMATORY BOWEL DISEASES: REALITY AND PROSPECTS
|
№s5-17 / 2017
|
|
I.G. Bakulin, T.N. Zhigalova, E.V. Skazyvaeva, M.I. Skalinskaya, S.I. Sitkin, E.A. Popova
EXPERIENCE OF INTRODUCTION OF THE FEDERAL REGISTRY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASES IN SAINT PETERSBURG
|
№s5-17 / 2017
|
|
I.G. Bakulin, T.V.Shkurko, A.I. Parfenov, O.V. Knyazev, N.A. Fadeeva, E.Yu. Zhulina, O.N. Boldyrev, E.I. Aliev
TOWARDS THE PREVALENCE AND INCIDENCE OF INFLAMMATORY BOWEL DISEASES IN MOSCOW
|
№2 / 2016
|
|
M.V. Shapina, I.L. Khalif, A.O. Golovenko, V.N. Kashnikov
FEATURES OF THE COURSE OF ULCERATIVE COLITIS DURING THERAPY WITH INFLIXIMAB
|
№15 / 2015
|
Русский
